QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts

$9.82
-0.15 (-1.50%)
(As of 12/8/2023 ET)
Compare
Today's Range
$9.80
▼
$9.98
50-Day Range
$8.12
▼
$10.07
52-Week Range
$7.09
▼
$11.44
Volume
4.40 million shs
Average Volume
10.24 million shs
Market Capitalization
$11.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.40
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 14Estimated
Actual EPS
(Nov. 8)
$0.60 Beat By $0.03
Consensus EPS
(Nov. 8)
$0.57
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teva Pharmaceutical Industries Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.53$0.62$0.58 
Q2 20232$0.49$0.55$0.52 
Q3 20232$0.55$0.56$0.56 
Q4 20232$0.61$0.68$0.65 
FY 20238$2.18$2.41$2.30 
Q1 20241$0.48$0.48$0.48 
Q2 20241$0.56$0.56$0.56 
Q3 20241$0.51$0.51$0.51 
Q4 20241$0.66$0.66$0.66 
FY 20244$2.21$2.21$2.21 
Q1 20251$0.44$0.44$0.44 
Q2 20251$0.56$0.56$0.56 

TEVA Earnings Date and Information

Teva Pharmaceutical Industries last announced its earnings results on November 8th, 2023. The reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.57 by $0.03. The business earned $3.90 billion during the quarter, compared to analyst estimates of $3.73 billion. Its revenue was up 8.3% compared to the same quarter last year. Teva Pharmaceutical Industries has generated ($1.98) earnings per share over the last year (($1.98) diluted earnings per share). Earnings for Teva Pharmaceutical Industries are expected to grow by 3.15% in the coming year, from $2.22 to $2.29 per share. Teva Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 14th, 2024 based off prior year's report dates.

Teva Pharmaceutical Industries Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/14/2024
Estimated)		------- 
11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73 billion$3.90 billion    
8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69 billion$3.88 billion
5/10/2023Q1 2023$0.55$0.37($0.18)$0.92$3.60 billion$3.66 billion
2/8/2023Q4 2022$0.64$0.68+$0.04$2.46$3.90 billion$3.88 billion
11/3/2022Q3 2022$0.58$0.56($0.02)$1.07$3.86 billion$3.60 billion    
7/26/2022Q2 2022$0.55$0.64+$0.09$1.49$3.82 billion$3.79 billion
5/3/2022Q1 2022$0.53$0.53-$1.92$3.75 billion$3.66 billion    
2/9/2022Q4 2021$0.70$0.74+$0.04$1.62$4.28 billion$4.10 billion    
10/27/2021Q3 2021$0.65$0.59($0.06)$0.88$4.05 billion$3.89 billion    
7/28/2021Q2 2021$0.55$0.59+$0.04$0.95$4.03 billion$3.91 billion    
4/28/2021Q1 2021$0.55$0.63+$0.08$1.13$4.04 billion$3.98 billion  
2/10/2021Q4 2020$0.63$0.68+$0.05$1.14$4.37 billion$4.45 billion  












Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

When is Teva Pharmaceutical Industries's earnings date?

Teva Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 14th, 2024 based off last year's report dates. Learn more on TEVA's earnings history.

Did Teva Pharmaceutical Industries beat their earnings estimates last quarter?

In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.60 earnings per share (EPS) to beat the analysts' consensus estimate of $0.57 by $0.03. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.

How can I listen to Teva Pharmaceutical Industries's earnings conference call?

The conference call for Teva Pharmaceutical Industries's latest earnings report can be listened to online. Listen to Conference Call

How can I read Teva Pharmaceutical Industries's conference call transcript?

The conference call transcript for Teva Pharmaceutical Industries's latest earnings report can be read online. Read Transcript

How much revenue does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.27 billion.

How much profit does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$2.35 billion. TEVA has generated -$1.98 earnings per share over the last four quarters.

What is Teva Pharmaceutical Industries's price-to-earnings ratio?

Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 4.43. The price/earnings-to-growth ratio is 1.01.

What is Teva Pharmaceutical Industries's EPS forecast for next year?

Teva Pharmaceutical Industries's earnings are expected to grow from $2.22 per share to $2.29 per share in the next year, which is a 3.15% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:TEVA) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -